Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways (mucostaph)
Characterisation of Mucoid Staphylococcus Aureus Recovered From the Airways of Cystic Fibrosis Patients: Prevalence and Impact on Clinical Course
Sponsor: University Hospital Muenster
Listed as NCT04171583, this observational or N/A phase trial focuses on Cystic Fibrosis and Lung Diseases and remains completed. Sponsored by University Hospital Muenster, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2022 — Mar 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2019 — Nov 2020 [monthly]
Recruiting
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital Muenster
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bochum, Germany , Cologne, Germany , Essen, Germany , Halle, Germany , Hanover, Germany , München, Germany , Münster, Germany , Rostock, Germany , Tübingen, Germany , Vienna, Austria and 1 more location